For: | Li J, Liu B, Yan LN, Wang LL, Lau WY, Li B, Wang WT, Xu MQ, Yang JY, Li FG. Microproteinuria for detecting calcineurin inhibitor-related nephrotoxicity after liver transplantation. World J Gastroenterol 2009; 15(23): 2913-2917 [PMID: 19533816 DOI: 10.3748/wjg.15.2913] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i23/2913.htm |
Number | Citing Articles |
1 |
K. Anastaze Stelle, D. C. Belli, P. Parvex, E. Girardin, A. Giroud, B. Wildhaber, V. A. McLin. Glomerular and tubular function following orthotopic liver transplantation in children treated with tacrolimus. Pediatric Transplantation 2012; 16(3): 250 doi: 10.1111/j.1399-3046.2011.01625.x
|
2 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2010; 19(1) doi: 10.1002/pds.1846
|
3 |
Ruben E A Musson, Christa M Cobbaert, Nico P M Smit. Molecular Diagnostics of Calcineurin-Related Pathologies. Clinical Chemistry 2012; 58(3): 511 doi: 10.1373/clinchem.2011.167296
|
4 |
Nicolas Pallet, Arjang Djamali, Christophe Legendre. Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: From toxicogenomics to emerging biomarkers. Pharmacological Research 2011; 64(1): 25 doi: 10.1016/j.phrs.2011.03.013
|
5 |
R. Deng, Y. Liao, Yi Li, J. Tang. Association of CYP3A5, CYP2C8, and ABCB1 Polymorphisms With Early Renal Injury in Chinese Liver Transplant Recipients Receiving Tacrolimus. Transplantation Proceedings 2018; 50(10): 3258 doi: 10.1016/j.transproceed.2018.06.040
|
6 |
Bin Liu, Jing Li, Lu-Nan Yan. Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets. Clinical and Developmental Immunology 2013; 2013: 1 doi: 10.1155/2013/325318
|
7 |
Yunying Shi, Yi Li, Jiangtao Tang, Junlong Zhang, Yuangao Zou, Bei Cai, Lanlan Wang. Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. Gene 2013; 512(2): 226 doi: 10.1016/j.gene.2012.10.048
|